| INTRODUC TI ON
The kidney is one of the organs affected in lipodystrophy. The aetiologic basis of renal complications associated with lipodystrophy has remained largely unknown; however, it is usually characterized by proteinuria. 4 Javor et al 5 reported that proteinuria was strikingly frequent in patients with generalized lipodystrophy who were being treated with metreleptin. Renal involvement has also been reported in the course of FPLD. [6] [7] [8] Renal involvement in acquired partial lipodystrophy (APL) has been associated with abnormalities of the alternative complement pathway, which is C3-nephritic factor associated mesangiocapillary glomerulonephritis (C3-MPGN).
3
Considering that novel treatments are in progress in lipodystrophy, it is essential to document the natural history of the disease and the disease burden in patients with lipodystrophy who are naïve to these lipodystrophy specific novel treatments. In this multicentre observational study, we specifically focused on renal complications.
We studied 103 novel drug naïve patients with various forms of lipodystrophy for renal abnormalities who were registered in the Turkish Lipodystrophy Study Group (TuLip) national registry. To better understand the pathogenesis of renal involvement in patients with lipodystrophy, we further investigated the renal biopsy samples of 9 patients.
| MATERIAL S AND ME THODS

| Patients
Initially, 109 patients non-HIV associated lipodystrophy from the TuLip registry were included in this study. None of the patients received metreleptin or any other drug in development for lipodystrophy at the time of data collection. Patients with specific syndromes such as mandibuloacral dysplasia, Short
Lipodystrophy Study Group database to study renal complications in treatment naïve patients with lipodystrophy. 
Methods
| Data collection and analysis
The prospective follow-up data were collected by the investigators at several centres of the TuLip. After reviewing the registry retrospectively, a final visit was scheduled to update the clinical findings.
Blood pressure was measured using a sphygmomanometer in the sitting position after 5-minute rest. For the adult age group, patients on antihypertensive treatment and those with resting blood pressure higher than 140/90 mm Hg were considered as hypertensive.
For the paediatric age group, adjusted blood pressure for age, height and gender higher than 95th percentile was considered as having hypertension.
Patients underwent a detailed physical examination, full bio- 
| Measurement of kidney volumes
Kidney morphology was studied on either ultrasound or MRI. Kidney volumes were measured on axial 3D GRE fat saturated T1 weighted MRI images (Achieva 1.5-T scanner, Philips Medical Systems, Best, the Netherlands) using Myrian software (IDS 2.0, Sectra AB, Sweden). The interpretation of the measurements was done as suggested by Cheong et al. 
| Renal biopsy
Percutaneous renal biopsies were performed in 9 patients. All patients had proteinuria and insulin resistant diabetes. Samples were stained with haematoxylin and eosin (HE), periodic acid-Schiff (PAS), periodic acid methenamine silver (PAM) stains and Congo-red in 2-3 micron sections. For immune deposits, each specimen was evaluated using antibodies against IgG, IgA, IgM, complement-3 (C3), complement-1q (C1q), kappa and lambda. Light microscopy, immunofluorescence and electron microscopy (EM) samples were read by three experienced pathologists. (Table 1) . Proteinuria was almost two times more common than retinopathy in patients with generalized lipodystrophy (Table S1) .
| Statistical analysis
Proteinuria was at nephrotic range in 5 patients (14%). Also, 10 additional patients (27%) with generalized lipodystrophy had hyper- Twenty-nine patients (44%) with partial lipodystrophy developed CKD associated with proteinuria (Table S2) . Three patients (5%) had proteinuria at nephrotic range. Five patients (8%) had hy- Figure 1A ; r = .499, P = .002
for the right kidney, Figure 1B ), HOMA-IR score (r = .435, P = .007
for the left kidney, Figure 1C ; r = .349, P = .034 for the right kidney, Figure 1D ) and HbA1c (r = .75, P < .001 for the left kidney; Figure 1E , r = .693, P < .001 for the right kidney, Figure 1F) ; and negatively correlated with leptin levels [r = −.295, P = .076 (not statistically significant) for the left kidney; Figure 1G , r = −.385, P = .019 for the right kidney, Fig. 1H ], when the data were controlled for age, gender, BMI and eGFR. 
F I G U R E 1
| D ISCUSS I ON
Although the kidney is one of the organs reported to be affected in the course of generalized lipodystrophy, the pathophysiology of renal damage has not been studied in a systematic fashion. In a pre- The loss of podocyte function, which contributes to the integrity of the glomerular filtration barrier, is a key event in the development of diabetic nephropathy. 23 Hyperfiltration, which was detected in several patients in our study, is an early abnormality leading to diabetic nephropathy. 24 However, we should note that formula-derived estimations are not always accurate in reflecting real renal function in patients with hyperfiltration or normal kidney functions. 19 Ludtke et al Epidemiological studies have shown that obesity and metabolic syndrome are independent predictors of CKD, which suggests that renal abnormalities may develop long before the appearance of diabetes in patients with insulin resistance. 26 Recently, several researchers described obesity-associated proteinuria which progresses to renal dysfunction that was associated with mesangial matrix expansion, glomerular hypertrophy and podocyte injury leading to the development of secondary FSGS. This specific type of FSGS was classified as an adaptive FSGS, which is thought to result from structural and functional adaptations which arise through mechanisms that place hemodynamic stress on an initially normal nephron population. 27 FSGS was a remarkable finding in our biopsy specimens. FSGS has previously been reported in patients with lipodystrophy. 4, 5, 28 One can assume that the pathogenesis of secondary FSGS, which is presumably due to the insulin resistance, might be somewhat common in obesity and lipodystrophy. FSGS may be secondarily mediated by structural-functional adaptations to glomerular hyperfiltration in these patients; however, cell auton- Renal involvement appears to be multifactorial and may at least be driven by either poorly controlled diabetes and/or the underlying severe insulin resistance. Also, ectopic lipid accumulation or specific genetic mechanisms can potentially play a role; however, further studies are needed to clarify the specific contributions of each of these factors to the chronic kidney disease of these syndromes.
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